Abstract
Small-molecule lead optimisation in early-stage drug discovery is broadly supported by computational chemistry approaches throughout industry. Over the last decade, Free Energy Perturbation (FEP) has grown into a mature physics-based tool that prospectively guides medicinal chemistry decision-making by accurately predicting ligand potencies at the level of precision that is required for the granular nature of the lead optimisation stage. Machine-learned ligand-protein co-folding models are at the forefront of accurate protein structure prediction and well-positioned to support early-stage drug discovery campaigns. This study investigates a hybrid framework that combines machine-learned ligand-protein co-folding models with FEP. By leveraging accurate pose and protein prediction, the method bypasses traditional, error-prone and time-consuming docking approaches, improving the reliability and scalability of FEP calculations. Benchmarking studies on a public kinase target (PFKFB3) and an internal target (target A) demonstrate that the hybrid framework achieves state-of-the-art accuracy while substantially lowering computational expense compared to more traditional FEP approaches. This approach integrates the machine learning and physical approach to affinity prediction, and represents a significant advancement in computational lead optimisation support, poising it to aid in accelerating the discovery of novel therapeutics.
Supplementary materials
Title
Leveraging Alchemical Free Energy Calculations with Accurate Protein Structure Prediction
Description
Supplementary information to the main text body
Actions
Supplementary weblinks
Title
Github repository
Description
Github repository with some of the predicted protein-ligand complexes
Actions
View